The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
STAT‐mediated EGFR signaling in cancer
Abstract
The epidermal growth factor receptor (EGFR) and signal transducers and activators of transcription (STATs) are commonly expressed and activated in many malignancies. EGFR is an upstream activator of several pathways involved in tumor progression, and STATs activate selected genes involved in oncogenesis. There are several different mechanisms by which STAT proteins can mediate intracellular EGFR signaling, including direct activation of STATs by EGFR binding and indirect activation of STATs through Src‐mediated EGFR signaling. EGFR likely activates STAT in a manner distinctive from other mechanisms of STAT activation; STAT5 can be phosphorylated in an EGF‐dependent manner at unique sites, conferring novel functions. Cumulative evidence suggests that targeting EGFR signaling pathways at several levels may demonstrate synergistic therapeutic effects compared with targeting the upstream receptor alone. Thus, methods to inhibit EGFR in conjunction with oncogenic STATs may represent a novel therapeutic strategy for cancers characterized by upregulation of EGFR signaling. J. Cell. Biochem. 102: 311–319, 2007. © 2007 Wiley‐Liss, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Darnell, J. E., Kerr, L. M., & Stark, G. R. (1994) · Science · doi:10.1126/science.8197455 · Cited by 6,080 · cited 1×
“Activated STATs form dimers and multiprotein complexes that translocate into the nucleus where target gene expression is initiated [Darnell et al., 1994].”
BackgroundBowman, T., Garcia, R., Turkson, J., & Jove, R. (2000) · Oncogene · doi:10.1038/sj.onc.1203527 · Cited by 1,743
Gefitinib-Sensitizing EGFR Mutations in Lung Cancer Activate Anti-Apoptotic Pathways
Sordella, R., Bell, D. W., Haber, D. A., & Settleman, J. (2004) · Science · doi:10.1126/science.1101637 · Cited by 1,606
A new protein containing an SH2 domain that inhibits JAK kinases
Endo, T. A., Masuhara, M., Yokouchi, M., Suzuki, R., Sakamoto, H., Mitsui, K., Matsumoto, A., Tanimura, S., Ohtsubo, M., Misawa, H., et al. (1997) · Nature · doi:10.1038/43213 · Cited by 1,408
Buettner, R., Mora, L. B., & Jove, R. (2002) · PubMed · Cited by 1,040
The Epidermal Growth Factor Receptor Pathway: A Model for Targeted Therapy
Scaltriti, M., & Baselga, J. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-1554 · Cited by 913
Serine phosphorylation of STATs
Decker, T., & Kovarik, P. (2000) · Oncogene · doi:10.1038/sj.onc.1203481 · Cited by 887
Garcia, R., Bowman, T. L., Niu, G., Yu, H., Minton, S., Muro-Cacho, C. A., Cox, C. E., Falcone, R., Fairclough, R., Parsons, S., et al. (2001) · Oncogene · doi:10.1038/sj.onc.1204349 · Cited by 756
Epidermal Growth Factor Receptor Biology in Head and Neck Cancer
Kalyankrishna, S., & Grandis, J. R. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.8306 · Cited by 747
Self-citationCritical Update and Emerging Trends in Epidermal Growth Factor Receptor Targeting in Cancer
Baselga, J., & Arteaga, C. L. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.11.890 · Cited by 725
Turkson, J., Ryan, D., Kim, J. S., Zhang, Y., Chen, Z., Haura, E., Laudano, A., Sebti, S., Hamilton, A. D., & Jove, R. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m107527200 · Cited by 448
Stat3 is required for ALK-mediated lymphomagenesis and provides a possible therapeutic target
Chiarle, R., Simmons, W. J., Cai, H., Dhall, G., Zamo, A., Raz, R., Karras, J. G., Levy, D. E., & Inghirami, G. (2005) · Nature Medicine · doi:10.1038/nm1249 · Cited by 442
Haura, E. B., Turkson, J., & Jove, R. (2005) · Nature Clinical Practice Oncology · doi:10.1038/ncponc0195 · Cited by 430
Corvinus, F. M., Orth, C., Moriggl, R., Tsareva, S. A., Wagner, S., Pfitzner, E. B., Baus, D., Kaufman, R., Huber, L. A., Zatloukal, K., et al. (2005) · Neoplasia · doi:10.1593/neo.04571 · Cited by 427
Role of STATs as downstream signal transducers in Src family kinase-mediated tumorigenesis
Silva, C. M. (2004) · Oncogene · doi:10.1038/sj.onc.1208159 · Cited by 403
Anaplastic lymphoma kinase (ALK) activates Stat3 and protects hematopoietic cells from cell death
Zamo, A., Chiarle, R., Piva, R., Howes, J., Fan, Y., Chilosi, M., Levy, D. E., & Inghirami, G. (2002) · Oncogene · doi:10.1038/sj.onc.1205152 · Cited by 399
SOCS-3 is frequently silenced by hypermethylation and suppresses cell growth in human lung cancer
He, B., You, L., Uematsu, K., Zang, K., Xu, Z., Lee, A. Y., Costello, J. F., McCormick, F., & Jablons, D. M. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2232790100 · Cited by 380
STAT signaling in head and neck cancer
Song, J. I., & Grandis, J. R. (2000) · Oncogene · doi:10.1038/sj.onc.1203483 · Cited by 374
Self-citationErbB Receptor-induced Activation of Stat Transcription Factors Is Mediated by Src Tyrosine Kinases
Olayioye, M. A., Beuvink, I., Horsch, K., Daly, J. M., & Hynes, N. E. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.24.17209 · Cited by 367
Structure, function, and regulation of STAT proteins
Lim, C. P., & Cao, X. (2006) · Molecular BioSystems · doi:10.1039/b606246f · Cited by 354
Ras-Independent Growth Factor Signaling by Transcription Factor Tyrosine Phosphorylation
Silvennoinen, O., Schindler, C., Schlessinger, J., & Levy, D. E. (1993) · Science · doi:10.1126/science.8378775 · Cited by 338
Signaling through the epidermal growth factor receptor during the development of malignancy
Grandis, J. R., & Sok, J. C. (2004) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2004.01.002 · Cited by 320
Self-citationGalm, O., Yoshikawa, H., Esteller, M., Osieka, R., & Herman, J. G. (2003) · Blood · doi:10.1182/blood-2002-06-1735 · Cited by 308
JAKs, STATs and Src kinases in hematopoiesis
Rane, S. G., & Reddy, E. P. (2002) · Oncogene · doi:10.1038/sj.onc.1205398 · Cited by 242
Haura, E. B., Zheng, Z., Song, L., Cantor, A., & Bepler, G. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-0827 · Cited by 223
STAT3 as a therapeutic target in head and neck cancer
Leeman, R. J., Lui, V. W. Y., & Grandis, J. R. (2006) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.6.3.231 · Cited by 223
Self-citationRajan, P., Panchision, D. M., Newell, L. F., & McKay, R. D. G. (2003) · The Journal of Cell Biology · doi:10.1083/jcb.200211021 · Cited by 207
Song, L., Morris, M., Bagui, T., Lee, F. Y., Jove, R., & Haura, E. B. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4620 · Cited by 204
Badache, A., & Hynes, N. E. (2001) · PubMed · Cited by 189
Xi, S., Gooding, W. E., & Grandis, J. R. (2005) · Oncogene · doi:10.1038/sj.onc.1208316 · Cited by 170
Self-citationSchaefer, L. K., Ren, Z., Fuller, G. N., & Schaefer, T. S. (2002) · Oncogene · doi:10.1038/sj.onc.1205263 · Cited by 170
木島, 太., Niwa, H., Steinman, R. A., Drenning, S. D., Gooding, W. E., Wentzel, A. L., Xi, S., & Grandis, J. R. (2002) · PubMed · Cited by 164
Self-citationNagel‐Wolfrum, K., Buerger, C., Wittig, I., Butz, K., Hoppe‐Seyler, F., & Groner, B. (2004) · Molecular Cancer Research · doi:10.1158/1541-7786.170.2.3 · Cited by 133
Gao, L., Zhang, L., Hu, J., Li, F., Shao, Y., Zhao, D., Kalvakolanu, D. V., Kopecko, D. J., Zhao, X., & Xu, D.-Q. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-0148 · Cited by 131
Xia, L., Wang, L., Chung, A. S., Ivanov, S. S., Ling, M. Y., Dragoi, A. M., Platt, A., Gilmer, T. M., Fu, X.-Y., & Chin, Y. E. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m202823200 · Cited by 127
Widschwendter, A., Geymayer, S., Welte, T., Daxenbichler, G., Marth, C., & Doppler, W. (2002) · PubMed · Cited by 108
Targeting Stat3 with G-Quartet Oligodeoxynucleotides in Human Cancer Cells
Jing, N., Li, Y., Xu, X., Sha, W., Li, P., Feng, L., & Tweardy, D. J. (2003) · DNA and Cell Biology · doi:10.1089/104454903770946665 · Cited by 92
Rosell, R., Tarón, M., Reguart, N., Isla, D., & Morán, T. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-0627 · Cited by 92
Boerner, J. L., Biscardi, J. S., Silva, C. M., & Parsons, S. J. (2005) · Molecular Carcinogenesis · doi:10.1002/mc.20138 · Cited by 74
Dowlati, A., Nethery, D. E., & Kern, J. A. (2004) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.459.3.4 · Cited by 67
Lewis, T. B., Robison, J. E., Bastien, R. R. L., et al. (2005) · Cancer · doi:10.1002/cncr.21372 · Cited by 61
Grb2 regulates Stat3 activation negatively in epidermal growth factor signalling
Zhang, T., Ma, J., & Cao, X. (2003) · Biochemical Journal · doi:10.1042/bj20030668 · Cited by 56
Quadros, M. R. D., Peruzzi, F., Kari, C., & Rodeck, U. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0214 · Cited by 56
Pyk2 Amplifies Epidermal Growth Factor and c-Src-induced Stat3 Activation
Shi, C.-S., & Kehrl, J. H. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m311875200 · Cited by 53
Activation state egfr and STAT-3 as prognostic markers in resected non-small cell lung cancer
Cortas, T., Eisenberg, R., Fu, P., Kern, J. A., Patrick, L. M., & Dowlati, A. (2006) · Lung Cancer · doi:10.1016/j.lungcan.2006.11.003 · Cited by 52
Arany, I., Chen, S.-H., Megyesi, J. K., Adler‐Storthz, K., Chen, Z., Rajaraman, S., Ember, I. A., Tyring, S. K., & Brysk, M. M. (2003) · Cancer Letters · doi:10.1016/s0304-3835(03)00345-8 · Cited by 39
Cited by
Interleukin-6 signaling pathway in targeted therapy for cancer
Guo, Y., Xu, F., Lu, T., Duan, Z., & Zhang, Z. (2012) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2012.04.007 · Cited by 686
The JAK2 Inhibitor AZD1480 Potently Blocks Stat3 Signaling and Oncogenesis in Solid Tumors
Hedvat, M., Huszar, D., Herrmann, A., Gozgit, J. M., Schroeder, A., Sheehy, A., Buettner, R., Proia, D., Kowolik, C. M., Xin, H., et al. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.10.015 · Cited by 526
Jhawer, M., Goel, S., Wilson, A. J., Montagna, C., Ling, Y.-H., Byun, D.-S., Nasser, S., Arango, D., Shin, J., Klampfer, L., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-5659 · Cited by 460
The role of HER2, EGFR, and other receptor tyrosine kinases in breast cancer
Hsu, J. L., & Hung, M.-C. (2016) · Cancer and Metastasis Reviews · doi:10.1007/s10555-016-9649-6 · Cited by 445
JAK/STAT pathway: Extracellular signals, diseases, immunity, and therapeutic regimens
Hu, Q., Bian, Q., Rong, D., Wang, L., Song, J., Huang, H.-S., Zeng, J., Mei, J., & Wang, P.-Y. (2023) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2023.1110765 · Cited by 339
Metadata
- Authors
- Quesnelle, K. M., Boehm, A. L., & Grandis, J. R.
- Venue
- Journal of Cellular Biochemistry
- Publisher
- Wiley
- Published
- 2007-07-27
- Volume
- 102
- Issue
- 2
- Pages
- 311-319
- ISSN
- 0730-2312 (ISSN-L)
- 1097-4644
- OpenAlex
- W2073723168
- Cited by
- 295
- References
- 46
- FWCI
- 6.04
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.